All In Biotech

Drug Trial Radar · NCT04091945

A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS

A Phase IIa, Double-Blind, Single Dose, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Potential Efficacy of LT3001 Drug Product in Subjects With Acute Ischemic Stroke (AIS)

Last checked: Nov 19, 2026Latest source record: Jan 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

24

Actual

Start

Jan 27, 2020

Primary completion

Feb 22, 2021

Study completion Feb 22, 2021

Sponsor

Lead sponsor
Lumosa Therapeutics Co., Ltd.Industry
Sponsor type
Industry
First posted
Sep 17, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, double-blind, single-dose, randomized, and placebo-controlled prospective Phase IIa clinical study, designed to evaluate LT3001 drug product versus placebo/control in subjects with AIS.

Conditions

  • Acute Ischemic Stroke

Interventions

  • LT3001 Drug ProductDrug

    Active comparator

  • PlaceboDrug

    Placebo comparator

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Percentage of Subject Have Symptomatic Intracranial Hemorrhage (sICH) of a Single Dose LT3001 Drug Product in Subjects With AIS.Time frame: Within 36 hours

Locations

10 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Kentucky Chandler Medical Center

    Lexington, Kentucky

  • JFK Neuroscience Institute, JFK Medical Center

    Edison, New Jersey

  • The Ohio State University - Wexner Medical Center

    Columbus, Ohio

  • Chattanooga Center for Neurologic Research

    Chattanooga, Tennessee

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    Kaohsiung City, Taiwan

  • Linkou Chang Gung Memorial Hospital

    New Taipei City, Taiwan

  • Taipei Medical University - Shuang Ho Hospital

    New Taipei City, Taiwan

  • China Medical University Hospital

    Taichung, Taiwan

  • Taichung Veterans General Hospital

    Taichung, Taiwan

  • Taipei Veterans General Hospital

    Taipei, Taiwan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.